ABBVIE A/S: Financial statements 2018
CVR: 34462828
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
ABBVIE A/S (CVR 34462828) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 452,915,118 and a net result of DKK 25,088,496 compared with DKK 20,902,364 the year before. That is a decrease of 18.2% compared with the year before. The profit margin was 5.5%. Equity in the 2018 report amounted to DKK 144,879,333. The solvency ratio was 72.2%. The company had 76 employees in the financial year.
- Revenue
- DKK 452,915,118
- Gross Profit
- DKK 123,597,664
- Profit/Loss
- DKK 25,088,496
- Equity
- DKK 144,879,333
- Total Assets
- DKK 200,679,198
- Employees
- 76
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 452.9 mio. | 123.6 mio. | 25.1 mio. | 144.9 mio. | 76 |
| 2017 | 553.9 mio. | 123.7 mio. | 20.9 mio. | 119.8 mio. | 78 |
| 2016 | 541.4 mio. | 123.2 mio. | 26.3 mio. | 118.9 mio. | 84 |
| 2015 | 568.2 mio. | 131.8 mio. | 21.5 mio. | 92.6 mio. | 96 |
| 2014 | 535.8 mio. | 114.2 mio. | 13.1 mio. | 71.1 mio. | 94 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
ABBVIE A/S has published its annual report for 2017. Revenue came to DKK 553,888,872, and the net result was DKK 20,902,364.
About ABBVIE A/S
ABBVIE A/S is a Danish company of the type Aktieselskab based in København N, founded in 2012. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named WCA PHARMACEUTICALS A/S. The management consists of Thea Larsen. The board consists of Matthew Robert Iles (chair), Arnaud Jean Jacques Coint-Bavarot, Jens Lange and Shitra Irari Amozurrutia Blancas. The company is owned by AbbVie Central Finance B.V.. The company has 59 employees (2026). In 2025, the company reported revenue of DKK 472,957,984 and a net result of DKK 25,023,523 compared with DKK 11,055,919 the year before. Equity in the 2025 report amounted to DKK 98,011,918.